Insider Transactions in Q2 2023 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2023
|
Elizabeth H Weatherman |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+3.05%
|
-
|
|
Jun 21
2023
|
Tony M. Chou |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+5.58%
|
-
|
|
Jun 21
2023
|
Donald Zurbay |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+41.0%
|
-
|
|
Jun 21
2023
|
Tanisha Carino |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+45.86%
|
-
|
|
Jun 21
2023
|
Jack W Lasersohn |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+30.13%
|
-
|
|
Jun 21
2023
|
Rick D Anderson |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+43.44%
|
-
|
|
Jun 21
2023
|
Kevin J. Ballinger |
BUY
Grant, award, or other acquisition
|
Direct |
4,691
+43.44%
|
-
|
|
Jun 12
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
1,000
-0.37%
|
$32,000
$32.13 P/Share
|
|
Jun 12
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+0.37%
|
$1,000
$1.6 P/Share
|
|
May 19
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
507
+0.43%
|
$13,182
$26.17 P/Share
|
|
May 19
2023
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
507
+0.25%
|
$13,182
$26.17 P/Share
|
|
May 19
2023
|
Marie L. Jones VP, Finance and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
506
+1.09%
|
$13,156
$26.17 P/Share
|
|
May 19
2023
|
Erica J. Rogers President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
507
+0.19%
|
$13,182
$26.17 P/Share
|
|
May 11
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.55%
|
$105,000
$35.51 P/Share
|
|
May 11
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+0.55%
|
$3,000
$1.6 P/Share
|
|
May 01
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-1.4%
|
$297,132
$44.51 P/Share
|
|
May 01
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+1.37%
|
$54,024
$8.89 P/Share
|
|
Apr 17
2023
|
Elizabeth H Weatherman |
SELL
Open market or private sale
|
Direct |
5,000
-3.35%
|
$205,000
$41.91 P/Share
|
|
Apr 11
2023
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
6,000
-2.18%
|
$234,000
$39.77 P/Share
|
|
Apr 11
2023
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+2.13%
|
$6,000
$1.6 P/Share
|
|
Apr 03
2023
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,753
-1.86%
|
$263,367
$39.42 P/Share
|
|
Apr 03
2023
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,753
+1.8%
|
$33,765
$5.19 P/Share
|